Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLOR: Colchicine in Chronic Coronary Syndromes
NCT07349875Phase 4Recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Jan 2026
- Primary completion
- Dec 2029
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine in coronary artery disease (CAD), sponsored by Nanjing First Hospital. Started Jan 2026; status: recruiting.
02
Drugs
colchicine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT07349875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07349875.